Nemus Bioscience and Nanomerics sign agreement to advance ocular formulation of NB-1111 March 22, 2017 No Comments
NightstaRx initiates phase I/II study of gene therapy to treat X-linked retinitis pigmentosa March 21, 2017 No Comments
RSS